PUBLICATION
Constitutively active CaMKII Drives B lineage acute lymphoblastic leukemia/lymphoma in tp53 mutant zebrafish
- Authors
- Rothschild, S.C., Lai, G., Tombes, R.M., Clements, W.K.
- ID
- ZDB-PUB-231221-9
- Date
- 2023
- Source
- PLoS Genetics 19: e1011102e1011102 (Journal)
- Registered Authors
- Clements, Wilson, Rothschild, Sarah Chase, Tombes, Robert M.
- Keywords
- none
- MeSH Terms
-
- Animals
- Calcium
- Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics
- Child
- Humans
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
- Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
- Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
- Zebrafish/genetics
- PubMed
- 38117861 Full text @ PLoS Genet.
Citation
Rothschild, S.C., Lai, G., Tombes, R.M., Clements, W.K. (2023) Constitutively active CaMKII Drives B lineage acute lymphoblastic leukemia/lymphoma in tp53 mutant zebrafish. PLoS Genetics. 19:e1011102e1011102.
Abstract
Acute lymphoblastic leukemia/lymphoma (ALL) is the most common pediatric cancer and is a malignancy of T or B lineage lymphoblasts. Dysregulation of intracellular Ca2+ levels has been observed in patients with ALL, leading to improper activation of downstream signaling. Here we describe a new zebrafish model of B ALL, generated by expressing human constitutively active CaMKII (CA-CaMKII) in tp53 mutant lymphocytes. In this model, B cell hyperplasia in the kidney marrow and spleen progresses to overt leukemia/lymphoma, with only 29% of zebrafish surviving the first year of life. Leukemic fish have reduced productive genomic VDJ recombination in addition to reduced expression and improper splicing of ikaros1, a gene often deleted or mutated in patients with B ALL. Inhibiting CaMKII in human pre-B ALL cells induced cell death, further supporting a role for CaMKII in leukemogenesis. This research provides novel insight into the role of Ca2+-directed signaling in lymphoid malignancy and will be useful in understanding disease development and progression.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping